Abstract:Organismal aging has been associated with diverse metabolic and functional changes across tissues. Within the immune system, key features of physiological hematopoietic cell aging include increased fat deposition in the bone marrow, impaired hematopoietic stem and progenitor cell (HSPC) function, and a propensity towards myeloid differentiation. This shift in lineage bias can lead to pre-malignant bone marrow conditions such as clonal hematopoiesis of indeterminate potential (CHIP) or clonal cytopenias of undetermined significance (CCUS), frequently setting the stage for subsequent development of age-related cancers in myeloid or lymphoid lineages. At the systemic as well as sub-cellular level, human aging has also been associated with diverse lipid alterations, such as decreased phospholipid membrane fluidity that arises as a result of increased saturated fatty acid (FA) accumulation and a decay in n-3 polyunsaturated fatty acid (PUFA) species by the age of 80 years, however the extent to which impaired FA metabolism contributes to hematopoietic aging is less clear. Here, we performed comprehensive multi-omics analyses and uncovered a role for a key PUFA biosynthesis gene, , in mouse and human immune cell aging. Whole transcriptome RNA-sequencing studies of bone marrow from aged mutant (enzyme-deficient) mice compared with age-matched controls revealed global down-regulation in lymphoid cell markers and expression of genes involved specifically in B cell development. Flow cytometric analyses of immune cell markers confirmed an aging-associated loss of B cell markers that was exacerbated in the bone marrow of mutant mice and unveiled CD79B, a vital molecular regulator of lymphoid progenitor development from the pro-B to pre-B cell stage, as a putative surface biomarker of accelerated immune aging. Complementary lipidomic studies extended these findings to reveal select alterations in lipid species in aged and mutant mouse bone marrow samples, suggesting significant changes in the biophysical properties of cellular membranes. Furthermore, single cell RNA-seq analysis of human HSPCs across the spectrum of human development and aging uncovered a rare subpopulation (<7%) of CD34+ HSPCs that expresses in healthy adult bone marrow. This HSPC subset, along with -expressing lymphoid-committed cells, were almost completely absent in CD34+ cells isolated from elderly (>60 years old) bone marrow samples. Together, these findings uncover new roles for lipid metabolism enzymes in the molecular regulation of cellular aging and immune cell function in mouse and human hematopoiesis. In addition, because systemic loss of ELOVL2 enzymatic activity resulted in down-regulation of B cell genes that are also associated with lymphoproliferative neoplasms, this study sheds light on an intriguing metabolic pathway that could be leveraged in future studies as a novel therapeutic modality to target blood cancers or other age-related conditions involving the B cell lineage.

B Cells Dynamic in Aging and the Implications of Nutritional Regulation

B Cells Promote T Cell Immunosenescence and Mammalian Aging Parameters

Characteristics of B Cells and B Cell Responses in Aged Individuals

Immune Alterations with Aging: Mechanisms and Intervention Strategies

Interaction of Aging and Immunosenescence: New Therapeutic Targets of Aging

Immunosenescence: A new direction in anti-aging research

Altered memory B-cell homeostasis in human aging.

B-cell capacity for differentiation changes with age

The role of autoantibodies in bridging obesity, aging, and immunosenescence

Human T cell immunosenescence and inflammation in aging

Systemic deficits in lipid homeostasis promote aging-associated impairments in B cell progenitor development

Metabolic requirements of human pro-inflammatory B cells in aging and obesity

Aging and Immune Function: Molecular Mechanisms to Interventions

“Inflamm‐aging” influences immune cell survival factors in human bone marrow

FOXP3<SUP>+</SUP> regulatory T cells and age-related diseases

Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention

Single-cell analysis of human peripheral blood reveals high immune response activity in successful ageing individuals

Molecular Markers of Blood Cell Populations Can Help Estimate Aging of the Immune System

Quantifiable Blood TCR Repertoire Components Associated with Immune Aging

Aging of the immune system: Focus on inflammation and vaccination

LONGITUDINAL TRAJECTORIES OF IMMUNE CELLS IN OLDER WOMEN: DATA FROM THE WOMEN’S HEALTH AND AGING STUDIES II